Health‐related quality of life among children with hereditary angioedema

The clinical expressions of hereditary angioedema with C1‐inhibitor deficiency (C1‐INH‐HAE) and its related burden may negatively affect patient quality of life. This study aimed to assess health‐related quality of life (HRQoL) in children with C1‐INH‐HAE.

[1]  H. Longhurst,et al.  The Humanistic, Societal, and Pharmaco-economic Burden of Angioedema , 2016, Clinical Reviews in Allergy & Immunology.

[2]  Yi Sun,et al.  QOL and sociodemographic factors among first-time parents in Japan: a multilevel analysis , 2016, Quality of Life Research.

[3]  W. Aberer,et al.  Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL. , 2016, The journal of allergy and clinical immunology. In practice.

[4]  L. Mallbris,et al.  Swedish children with hereditary angioedema report good overall health and quality of life despite symptoms , 2016, Acta paediatrica.

[5]  H. Kandemir,et al.  Assessment of psychiatric morbidity and quality of life in children and adolescents with cutaneous leishmaniasis and their parents , 2015, Postepy dermatologii i alergologii.

[6]  A. Bygum,et al.  Health-related quality of life in Danish patients with hereditary angioedema. , 2015, Acta dermato-venereologica.

[7]  L. Mallbris,et al.  Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden. , 2014, Allergy and asthma proceedings.

[8]  A. Gompel,et al.  Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. , 2013, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  I. Dotan,et al.  Long-term Functional and Quality-of-Life Outcomes After IPAA in Children , 2013, Diseases of the colon and rectum.

[10]  R. Campos,et al.  Hereditary angioedema: quality of life in Brazilian patients , 2013, Clinics.

[11]  K. Bork,et al.  Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. , 2012, The Journal of allergy and clinical immunology.

[12]  T. Machnig,et al.  C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life. , 2012, Allergy and asthma proceedings.

[13]  E. Remor,et al.  Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project , 2012, Health and Quality of Life Outcomes.

[14]  C. Fagerberg,et al.  Mutational spectrum and phenotypes in Danish families with hereditary angioedema because of C1 inhibitor deficiency , 2011, Allergy.

[15]  U. Nzeako.  Diagnosis and management of angioedema with abdominal involvement: a gastroenterology perspective. , 2010, World journal of gastroenterology.

[16]  W. Lumry,et al.  The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. , 2010, Allergy and asthma proceedings.

[17]  J. Varni,et al.  Measuring health-related quality of life in Hungarian children with heart disease: psychometric properties of the Hungarian version of the Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales and the Cardiac Module , 2010, Health and quality of life outcomes.

[18]  H. Stenlund,et al.  Psychometric properties of the Swedish PedsQL, Pediatric Quality of Life Inventory 4.0 generic core scales , 2009, Acta paediatrica.

[19]  F. Freitag.  The cycle of migraine: patients' quality of life during and between migraine attacks. , 2007, Clinical therapeutics.

[20]  J. Levy,et al.  The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema , 2006, Expert opinion on investigational drugs.

[21]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[22]  B. Reichman,et al.  Health-related quality of life among children and adolescents: associations with obesity , 2006, International Journal of Obesity.

[23]  J. Laurent,et al.  Œdème angioneurotique héréditaire : à propos d'une observation chez un enfant de trois ans , 2005 .

[24]  M. López-Trascasa,et al.  Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[25]  J. Varni,et al.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. , 2001, Medical care.

[26]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[27]  K. Beusterien,et al.  The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. , 2014, Allergy and asthma proceedings.

[28]  D. Lundy,et al.  Health and Quality of Life Outcomes , 2008 .

[29]  J. Varni,et al.  The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity. , 2006, Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation.

[30]  M. Guillot,et al.  [Hereditary angioneurotic edema: a case report in a 3-year-old child]. , 2005, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[31]  P. Keith,et al.  ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access , 2022 .